Multiple Myeloma

Category

State of the Science for Multiple Myeloma: Change in the Right Direction

In a workshop held by the FDA in partnership with the American Association for Cancer Research (AACR) on February 13, 2019 in Wardman Park, Washington D.C., researchers from various institutions discussed the current state of African American outcomes and treatment in...

Cancer Treatment Centers of America Investigators Dose First Patient in Experimental Immuno-Oncology Clinical Trial

Cancer Treatment Centers of America® (CTCA) clinical investigators based in Phoenix have dosed the first patient in the first-in-human study of NKTR-255, a first-in-class immunotherapy. This Phase I clinical trial is designed to evaluate the safety and tolerability of...

Multiple Myeloma Research Foundation (MMRF) Launches Direct-to-Patient Registry Powered by ‘CureCloud’ in Quest for Precision Therapies

The Multiple Myeloma Research Foundation (MMRF) launched its Direct-to-Patient (DTP) Registry as a way to invite patients with multiple myeloma to securely submit their health data to MMRF CureCloud, the foundations data repository. This represents the fist data...

Multiple Myeloma Research Consortium Launches Immune Atlas Advancing Personalized Myeloma Treatments

The Multiple Myeloma Research Consortium has launched an immune atlas advancing personalized myeloma treatments. Multiple myelomas, also known as plasma cell myeloma, is a cancer of plasma cells. A type of white blood cell which normally produces antibodies, often no...

Pin It on Pinterest